Medicare Enrolled

Dr. Carolyn Jenks, D.O.

Internal Medicine · Tyler, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
501 SAUNDERS AVE STE 200, Tyler, TX 75702
9035799800
In practice since 2012 (13 years)
NPI: 1730447558 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jenks from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jenks? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jenks

Dr. Carolyn Jenks is an internal medicine specialist in Tyler, TX, with 13 years of NPI registration. Based on federal Medicare data, Dr. Jenks performed 82,465 Medicare services across 3,304 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jenks received a total of $1,593 from 22 pharmaceutical and/or device companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jenks is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 13 years in practice ▲ Top 1% volume in TX $1,593 industry payments

Medicare Practice Summary

Medicare Utilization ↗
82,465
Medicare services
Top 1% in TX for internal medicine
3,304
Unique beneficiaries
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,343 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme) 14,790 $0 $5
Pembrolizumab injection (Keytruda) 11,800 $44 $137
Paclitaxel chemotherapy injection 9,054 $0 $8
Oxaliplatin chemotherapy injection 7,480 $0 $33
Nivolumab injection (Opdivo) 5,980 $24 $76
Darbepoetin injection (Aranesp) for anemia 5,610 $2 $20
Iron sucrose injection (Venofer) 5,200 $0 $2
Contrast dye for imaging (iodine-based) 5,050 $0 $3
Daratumumab injection (Darzalex) 4,680 $38 $128
Dexamethasone injection (steroid) 1,956 $0 $1
Immune globulin infusion (Octagam) 1,580 $34 $235
Denosumab injection (Prolia/Xgeva) 780 $18 $66
Blood draw (venipuncture) 727 $8 $20
Comprehensive metabolic blood panel 699 $10 $64
Complete blood count (CBC) with differential 652 $8 $36
Injection, granisetron hydrochloride, 100 mcg 580 $0 $24
Office visit, established patient (30-39 min) 510 $89 $368
Injection of additional new drug or substance into vein 450 $12 $108
Anti-nausea injection (Aloxi/palonosetron) 450 $1 $114
Injection, leucovorin calcium, per 50 mg 361 $3 $25
Injection, carboplatin, 50 mg 356 $2 $300
Injection, fluorouracil, 500 mg 319 $2 $13
Administration of chemotherapy into vein, 1 hour or less 298 $98 $707
Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session 281 $266 $2,762
Injection, zoledronic acid, 1 mg 196 $7 $431
Injection, pegfilgrastim, excludes biosimilar, 0.5 mg 156 $75 $1,348
Injection, potassium chloride, per 2 meq 150 $0 $1
Cyclophosphamide, 100 mg 143 $15 $203
Immunoglobulin level test 132 $9 $56
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 130 $22 $157
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 124 $48 $313
Injection, diphenhydramine hcl, up to 50 mg 101 $1 $7
Administration of additional new drug or substance into vein, 1 hour or less 100 $49 $344
Administration of chemotherapy into vein, each additional hour 91 $21 $161
Lactate dehydrogenase (enzyme) level 85 $6 $31
Drug injection, under skin or into muscle 83 $11 $96
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 69 $55 $211
Magnesium level test 67 $7 $29
Complete blood count (CBC), automated 65 $6 $34
Injection, fosnetupitant 235 mg and palonosetron 0.25 mg 65 $330 $1,722
Microscopic examination for white blood cells with manual cell count 64 $4 $22
Injection, magnesium sulfate, per 500 mg 60 $1 $6
Office visit, established patient (20-29 min) 57 $53 $250
Radiation treatment delivery,3 or more separate treatment areas, custom blocking, tangential ports, wedges, rotational beam, compensators, electron beam; 11-19 mev 57 $172 $700
Unclassified drugs 57 $1 $8
Reticulated (young) platelet measurement 56 $35 $143
Ct scan of chest with contrast 54 $49 $821
Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services 53 $71 $70
Iron level test 52 $6 $27
Iron binding capacity test 52 $9 $35
Ferritin level test (iron stores) 51 $13 $60
CT scan of abdomen and pelvis with contrast 39 $170 $1,067
New patient office visit (45-59 min) 38 $120 $565
Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l 36 $124 $500
Hospital follow-up visit, high complexity 31 $88 $357
Infusion into a vein for therapy, prevention, or diagnosis, each additional hour 30 $16 $100
Administration of additional new drug or substance into vein using push technique 28 $42 $289
Hospital follow-up visit, moderate complexity 28 $61 $247
Carcinoembryonic antigen (cea) protein level 27 $19 $99
Irrigation of implanted venous access drug delivery device 24 $19 $114
Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion 23 $15 $94
Urea nitrogen level to assess kidney function, quantitative 21 $4 $24
Infusion, normal saline solution , 1000 cc 21 $2 $19
Manual urinalysis test with examination using microscope, non-automated 18 $4 $26
Vitamin B-12 level test 16 $15 $76
Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 16 $20 $128
Infusion, normal saline solution, sterile (500 ml = 1 unit) 16 $1 $19
Drawing of blood for a medical problem 14 $68 $264
CT scan of chest, without contrast 13 $30 $686
Application of on-body injector for under skin injection 13 $14 $96
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
20.3% high complexity
74.6% medium
5.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$1,593
Total received (2018-2024)
Avg $228/year across 7 years
Top 33% in TX for internal medicine
22
Companies
58
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,231 (77.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$362 (22.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$484
2023
$244
2022
$102
2021
$382
2020
$134
2019
$190
2018
$56

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Athenex Pharmaceutical Division, LLC
$350
Takeda Pharmaceuticals U.S.A., Inc.
$204
Tempus AI, Inc
$166
ABBVIE INC.
$138
Amgen Inc.
$124
Pharmacyclics LLC, An AbbVie Company
$91
Myriad Genetic Laboratories, Inc.
$91
Novartis Pharmaceuticals Corporation
$55
Gilead Sciences, Inc.
$51
Exelixis Inc.
$42
PFIZER INC.
$39
Kite Pharma, Inc.
$35
E.R. Squibb & Sons, L.L.C.
$35
Regeneron Healthcare Solutions, Inc.
$29
Pharmacyclics LLC, an AbbVie Company
$26
Lilly USA, LLC
$21
CTI BioPharma Corp.
$20
JAZZ PHARMACEUTICALS INC.
$19
AbbVie Inc.
$16
Novocure Inc.
$15
Janssen Pharmaceuticals, Inc
$14
Fortovia Therapeutics, Inc.
$12
Top 3 companies account for 45.2% of total payments
Associated products mentioned in payments ›
Cabometyx · ELREXFIO · EPKINLY · IMBRUVICA · KISQALI · LIBTAYO · MEKINIST · MYRISK · NINLARO · Optune · TABRECTA · VERZENIO · VYXEOS · Vonjo · XALKORI · XARELTO · XT CDX · Yescarta · Zydelig
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (77%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $2 per 100 Medicare services performed
Looking for an internal medicine specialist in Tyler?
Compare internal medicine physicians in the Tyler area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
170
Per 100K population
71.4
County median income
$71,923
Nearest hospital
UT HEALTH EAST TEXAS TYLER REGIONAL HOSPITAL
3.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Jenks is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Jenks experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Jenks performed 14,790 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jenks receive payments from pharmaceutical companies?
Yes. Dr. Jenks received a total of $1,593 from 22 companies across 58 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jenks's costs compare to other internal medicine physicians in Tyler?
Dr. Jenks's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jenks) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →